Henry Tietz is a medical student who is interested in immunological leukemia control. He is leveraging single cell RNA sequencing data and immunopeptidomes to identify targets for T cell discovery.
Penter Lab
Cancer and immune cell co-evolution at Charité - Universitätsmedizin Berlin
Henry Tietz is a medical student who is interested in immunological leukemia control. He is leveraging single cell RNA sequencing data and immunopeptidomes to identify targets for T cell discovery.